Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Citroma

Last content change checked dailysee data sync status

Active ingredient
Magnesium Citrate 1.745 g/29.6 mL
Other brand names
Drug classes
Calculi Dissolution Agent, Osmotic Laxative
Dosage form
Liquid
Route
Oral
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2018
Label revision date
February 23, 2026
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Magnesium Citrate 1.745 g/29.6 mL
Other brand names
Drug classes
Calculi Dissolution Agent, Osmotic Laxative
Dosage form
Liquid
Route
Oral
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2018
Label revision date
February 23, 2026
Manufacturer
Better Living Brands, LLC
Registration number
M007
NDC root
21130-709
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Magnesium Citrate is an oral solution that acts as a saline laxative, helping to relieve occasional constipation (irregularity). It works by drawing water into the intestines, which can stimulate a bowel movement typically within 30 minutes to 6 hours after taking it. This product is available in a pleasant lemon flavor and is saccharin-free, making it a suitable option for those looking for a gentle way to alleviate constipation.

Uses

If you're experiencing occasional constipation (irregularity), this medication can help provide relief. It works by stimulating your bowels, typically resulting in a bowel movement within 1/2 to 6 hours after taking it.

You can feel confident using this medication, as there are no known teratogenic effects (harmful effects on fetal development) or nonteratogenic effects (not harmful to fetal development) associated with it.

Dosage and Administration

Before you take your medication, make sure to shake the bottle well. When you're ready to take your dose, drink a full glass of liquid—about 8 ounces—along with it. You can take your medication either as a single dose each day or split it into smaller doses throughout the day.

For adults and children aged 12 and older, the recommended dose is between 6.5 to 10 fluid ounces, but you should not exceed 10 fluid ounces in a 24-hour period. If your child is between 6 and 12 years old, they should take between 3 to 7 fluid ounces, with a maximum of 7 fluid ounces in a day. For younger children aged 2 to under 6 years, the dose is 2 to 3 fluid ounces, not exceeding 3 fluid ounces in 24 hours. If your child is under 2 years old, it's important to consult a doctor before giving them this medication.

What to Avoid

It's important to be aware of certain precautions when using this medication. You should stop using it and consult your doctor if you experience rectal bleeding or if you do not have a bowel movement after using it. These symptoms could indicate a serious health issue that requires medical attention.

Currently, there are no specific contraindications, controlled substance classifications, or noted risks of abuse, misuse, or dependence associated with this medication. However, always prioritize your health and safety by following the guidance provided.

Side Effects

If you experience rectal bleeding or do not have a bowel movement after using this medication, it is important to stop using it and consult your doctor. These symptoms could indicate a serious condition that requires medical attention. Always prioritize your health and seek guidance if you have any concerns.

Warnings and Precautions

It's important to be aware of some key warnings when using this product. If you suspect an overdose, seek emergency medical help immediately or contact a Poison Control Center.

You should also stop using the product and call your doctor if you experience rectal bleeding or if you do not have a bowel movement after using it. These symptoms could indicate a serious health issue that needs attention. Always prioritize your health and safety by staying informed and proactive.

Overdose

It appears that there is no specific information available regarding overdosage for this medication. However, it's important to be aware of the general signs of an overdose, which can include symptoms like extreme drowsiness, confusion, or difficulty breathing. If you suspect an overdose, it is crucial to seek immediate medical help.

In case of an emergency, call your local emergency number or go to the nearest hospital. Always keep medications out of reach of children and follow the prescribed dosage to prevent any potential risks. If you have any concerns or questions about your medication, don’t hesitate to reach out to your healthcare provider for guidance.

Pregnancy Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using this medication. They can provide guidance on whether it’s safe for you and your baby. Always prioritize your health and the health of your child by seeking expert advice.

Lactation Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using any medication. This ensures that you understand any potential risks and can make informed decisions about your health and the health of your baby. Always prioritize open communication with your doctor regarding your breastfeeding journey.

Pediatric Use

When it comes to giving this medication to children, it's important to follow specific guidelines based on their age. For children aged 12 years and older, the maximum amount you can give in a 24-hour period is 10 fluid ounces, with a typical range of 6.5 to 10 fluid ounces. For those between 6 and under 12 years old, the limit is 7 fluid ounces, with a recommended range of 3 to 7 fluid ounces.

If your child is between 2 and under 6 years old, they should receive no more than 3 fluid ounces in a day, with a typical dose of 2 to 3 fluid ounces. For children under 2 years of age, it's crucial to consult a doctor before administering this medication. Always ensure you adhere to these guidelines to keep your child safe.

Geriatric Use

If you are an older adult or caring for one, it's important to be cautious when using this medication. Before starting, consult with your doctor, especially if you have kidney disease, as this can affect how the medication works in your body. Additionally, if you are taking other medications, check with your doctor or pharmacist to avoid any potential interactions.

Be alert for any unusual symptoms while using this medication. If you experience rectal bleeding or do not have a bowel movement after use, stop taking the medication and contact your doctor immediately, as these could indicate a more serious health issue. Your safety and well-being are the top priority, so don't hesitate to seek guidance.

Renal Impairment

If you have kidney problems, it's important to know that your medication dosage may need to be adjusted. Specifically, if your creatinine clearance (a measure of kidney function) is reduced, your healthcare provider will closely monitor your condition. Regular renal function tests are essential to ensure your kidneys are working properly and to help guide any necessary changes in your treatment.

For those with significant renal impairment, a reduced dose of medication is recommended to avoid potential complications. Always communicate with your healthcare team about your kidney health, as they will provide the best guidance tailored to your needs.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you if you have hepatic impairment (liver issues).

Always consult your healthcare provider for personalized advice and to discuss any concerns regarding your liver health and how it may relate to your treatment. They can help ensure that your medication is safe and effective for you.

Drug Interactions

It's important to be aware that certain medications can interact with each other, which may affect how well they work. For example, if you are taking laxatives like magnesium citrate, it's recommended to take them at least 2 hours before or after other medications. This helps ensure that the laxative does not interfere with the effectiveness of your other drugs.

Always discuss any medications you are taking with your healthcare provider. They can help you understand potential interactions and ensure that your treatment plan is safe and effective.

Storage and Handling

To ensure the best performance of your product, store it in a cool, dry place at temperatures between 46°F and 86°F (8°C and 30°C). This temperature range helps maintain the product's effectiveness and safety.

When handling the product, be sure to do so with clean hands and in a clean environment to avoid contamination. Always follow any specific disposal instructions provided to ensure safe and responsible disposal.

Additional Information

No further information is available.

FAQ

What is Magnesium Citrate?

Magnesium Citrate is an oral saline laxative solution used for the relief of occasional constipation.

How does Magnesium Citrate work?

It generally produces a bowel movement within 1/2 to 6 hours after ingestion.

What is the recommended dosage for adults and children over 12?

Adults and children 12 years and older should take 6.5 to 10 fl oz, with a maximum of 10 fl oz in 24 hours.

What should children aged 6 to under 12 take?

Children aged 6 to under 12 years should take 3 to 7 fl oz, with a maximum of 7 fl oz in 24 hours.

Is there a dosage for children under 2 years?

For children under 2 years of age, you should ask a doctor before use.

What precautions should I take before using Magnesium Citrate?

Ask a doctor before use if you have kidney disease or are taking any other drugs.

What should I do if I experience rectal bleeding?

Stop use and ask a doctor if you have rectal bleeding or failure to have a bowel movement after use, as these could indicate a serious condition.

Can I use Magnesium Citrate if I am pregnant or breastfeeding?

If pregnant or breastfeeding, you should ask a health professional before use.

How should I store Magnesium Citrate?

Store Magnesium Citrate at temperatures between 46° and 86°F (8° and 30° C).

What should I do in case of an overdose?

In case of overdose, get medical help or contact a Poison Control Center immediately.

Packaging Info

Below are the non-prescription pack sizes of Citroma (magnesium citrate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Citroma.
Details

Drug Information (PDF)

This file contains official product information for Citroma, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the relief of occasional constipation (irregularity). It generally produces a bowel movement within 1/2 to 6 hours of administration.

Limitations of Use: There are no known teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The medication should be shaken well before use. It is recommended that patients drink a full glass (8 ounces) of liquid with each dose to ensure proper administration.

For adults and children aged 12 years and older, the dosage ranges from 6.5 to 10 fluid ounces, with a maximum limit of 10 fluid ounces within a 24-hour period.

For children aged 6 to under 12 years, the appropriate dosage is between 3 to 7 fluid ounces, not exceeding 7 fluid ounces in a 24-hour period.

For children aged 2 to under 6 years, the dosage should be between 2 to 3 fluid ounces, with a maximum of 3 fluid ounces in a 24-hour period.

For children under 2 years of age, it is advised to consult a physician for appropriate dosing recommendations.

The medication may be administered as a single daily dose or divided into multiple doses as deemed necessary.

Contraindications

Use is contraindicated in patients experiencing rectal bleeding or failure to have a bowel movement after use, as these symptoms may indicate a serious underlying condition. In such cases, it is essential to seek medical advice promptly.

Warnings and Precautions

In the event of an overdose, it is imperative to seek emergency medical assistance immediately or contact a Poison Control Center. Prompt action is crucial to ensure patient safety and mitigate potential adverse effects.

Patients should discontinue use and consult a healthcare professional if they experience rectal bleeding or fail to have a bowel movement after administration. These symptoms may indicate a serious underlying condition that requires further evaluation and intervention.

Healthcare providers are advised to monitor patients closely for these signs and symptoms to ensure timely management and to prevent complications associated with the use of this product.

Side Effects

Patients should discontinue use and consult a healthcare professional if they experience rectal bleeding or failure to have a bowel movement after use, as these symptoms may indicate a serious underlying condition.

Drug Interactions

Laxatives, particularly magnesium citrate, may influence the efficacy of concomitantly administered medications. It is recommended that magnesium citrate be taken at least 2 hours before or after the administration of other drugs to minimize potential interactions.

No additional drug interactions or interactions with laboratory tests have been identified. Therefore, no specific dosage adjustments or monitoring recommendations are necessary beyond the guidance provided for magnesium citrate.

Packaging & NDC

Below are the non-prescription pack sizes of Citroma (magnesium citrate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Citroma.
Details

Pediatric Use

Pediatric patients aged 12 years and older may receive a dosage of 6.5 to 10 fl oz, with a maximum limit of 10 fl oz in a 24-hour period. For children aged 6 to under 12 years, the recommended dosage ranges from 3 to 7 fl oz, not exceeding 7 fl oz in 24 hours. In children aged 2 to under 6 years, the dosage is 2 to 3 fl oz, with a maximum of 3 fl oz in 24 hours. For infants and children under 2 years of age, it is advised to consult a doctor before administration.

Geriatric Use

Elderly patients should consult a healthcare provider prior to using this medication, particularly if they have a history of kidney disease. It is essential for geriatric patients to inform their doctor or pharmacist about any other medications they are currently taking to avoid potential drug interactions.

Additionally, if an elderly patient experiences rectal bleeding or fails to have a bowel movement after using this product, they should discontinue use immediately and seek medical advice, as these symptoms may indicate a serious underlying condition. Careful monitoring and appropriate dose adjustments may be necessary to ensure the safety and efficacy of treatment in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is essential to evaluate the potential risks and benefits associated with its use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Renal impairment may necessitate dosage adjustments for patients with reduced kidney function. It is essential that patients with reduced creatinine clearance are closely monitored to ensure safety and efficacy. Regular renal function tests should be performed in patients with kidney problems to assess their condition. A reduced dose is recommended for patients with significant renal impairment to mitigate the risk of adverse effects.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

There is currently no specific information available regarding overdosage for this medication. Healthcare professionals are advised to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Patients should be evaluated for potential complications, and appropriate interventions should be implemented based on clinical judgment.

For further guidance, healthcare professionals may refer to established protocols for managing overdosage of similar agents or consult a poison control center.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center in the event of an overdose. It is important for patients to be aware of the signs that warrant discontinuation of the product; they should stop use and consult a doctor if they experience rectal bleeding or if they fail to have a bowel movement after use, as these symptoms may indicate a serious condition.

Patients should be encouraged to consult with their healthcare provider prior to use if they have any of the following conditions: kidney disease, a magnesium or sodium restricted diet, abdominal pain, nausea, or vomiting. Additionally, patients should inform their healthcare provider if they have noticed a sudden change in bowel habits that persists for more than two weeks or if they have been using a laxative for longer than one week.

Furthermore, patients should be instructed to ask a doctor or pharmacist before using this product if they are currently taking any other medications. It is essential to take this product at least two hours before or after other medications, as laxatives may influence the effectiveness of other drugs.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at temperatures ranging from 46° to 86°F (8° to 30°C) to maintain its efficacy and safety. Proper storage conditions must be adhered to, ensuring that the product is kept within the specified temperature range to prevent degradation.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Citroma, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Citroma, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.